1. Home
  2. TECH vs MORN Comparison

TECH vs MORN Comparison

Compare TECH & MORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • MORN
  • Stock Information
  • Founded
  • TECH 1976
  • MORN 1984
  • Country
  • TECH United States
  • MORN United States
  • Employees
  • TECH N/A
  • MORN N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • MORN Investment Managers
  • Sector
  • TECH Health Care
  • MORN Finance
  • Exchange
  • TECH Nasdaq
  • MORN Nasdaq
  • Market Cap
  • TECH 8.2B
  • MORN 9.5B
  • IPO Year
  • TECH 1989
  • MORN 2005
  • Fundamental
  • Price
  • TECH $60.60
  • MORN $227.60
  • Analyst Decision
  • TECH Buy
  • MORN Buy
  • Analyst Count
  • TECH 12
  • MORN 3
  • Target Price
  • TECH $70.64
  • MORN $361.67
  • AVG Volume (30 Days)
  • TECH 2.9M
  • MORN 528.0K
  • Earning Date
  • TECH 10-29-2025
  • MORN 10-29-2025
  • Dividend Yield
  • TECH 0.53%
  • MORN 0.80%
  • EPS Growth
  • TECH N/A
  • MORN 64.83
  • EPS
  • TECH 0.46
  • MORN 9.41
  • Revenue
  • TECH $1,219,635,000.00
  • MORN $2,347,400,000.00
  • Revenue This Year
  • TECH $3.97
  • MORN $8.04
  • Revenue Next Year
  • TECH $7.81
  • MORN $7.65
  • P/E Ratio
  • TECH $131.65
  • MORN $24.27
  • Revenue Growth
  • TECH 5.23
  • MORN 8.23
  • 52 Week Low
  • TECH $46.01
  • MORN $221.02
  • 52 Week High
  • TECH $80.80
  • MORN $365.00
  • Technical
  • Relative Strength Index (RSI)
  • TECH 59.12
  • MORN 27.33
  • Support Level
  • TECH $50.13
  • MORN $221.02
  • Resistance Level
  • TECH $63.23
  • MORN $238.04
  • Average True Range (ATR)
  • TECH 2.26
  • MORN 4.61
  • MACD
  • TECH 0.76
  • MORN -0.10
  • Stochastic Oscillator
  • TECH 65.25
  • MORN 22.38

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

Share on Social Networks: